Importer of Controlled Substances; Notice of Registration; Almac Clinical Services, Inc., 50162-50163 [2012-20370]

Download as PDF 50162 Federal Register / Vol. 77, No. 161 / Monday, August 20, 2012 / Notices Additional written submissions to the Commission, including requests pursuant to section 201.12 of the Commission’s rules, shall not be accepted unless good cause is shown for accepting such submissions, or unless the submission is pursuant to a specific request by a Commissioner or Commission staff. In accordance with sections 201.16(c) and 207.3 of the Commission’s rules, each document filed by a party to the investigations must be served on all other parties to the investigations (as identified by either the public or BPI service list), and a certificate of service must be timely filed. The Secretary will not accept a document for filing without a certificate of service. Authority: These investigations are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to section 207.21 of the Commission’s rules. By order of the Commission. Issued: August 15, 2012. Lisa R. Barton, Acting Secretary to the Commission. [FR Doc. 2012–20372 Filed 8–17–12; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE 1. On page 47109, in the third column, the document heading should appear as set forth above. 2. On page 47110, in the second column, in the first full paragraph, in the eighth line of text, ‘‘September 6, 2012’’ should read ‘‘September 19, 2012’’. DEPARTMENT OF JUSTICE [FR Doc. C1–2012–19197 Filed 8–17–12; 8:45 am] In notice document 2012–19199 appearing on pages 47108–47109 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47108, in the third column, the document heading should appear as set forth above. 2. On page 47109, in the sixth paragraph following the table, in the eighth line of text, ‘‘September 6, 2012’’ should read ‘‘September 19, 2012’’. BILLING CODE 1505–01–D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Lipomed Correction [FR Doc. C1–2012–19196 Filed 8–17–12; 8:45 am] Importer of Controlled Substances; Notice of Application; SA INTL GMBH C/O., Sigma Aldrich Co., LLC BILLING CODE 1505–01–D [FR Doc. C1–2012–19191 Filed 8–17–12; 8:45 am] BILLING CODE 1505–01–D DEPARTMENT OF JUSTICE mstockstill on DSK4VPTVN1PROD with NOTICES Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; Clinical Supplies Management, Inc. DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Application; R & D Systems, Inc. Correction In notice document 2012–19193 appearing on pages 47110–47111 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47110, in the third column, the document heading should appear as set forth above. 2. On page 47110, in the fifth paragraph following the table, in the eighth line of text, ‘‘September 6, 2012’’ should read ‘‘September 19, 2012’’. [FR Doc. C1–2012–19193 Filed 8–17–12; 8:45 am] BILLING CODE 1505–01–D Correction In notice document 2012–19197 appearing on pages 47109–47110 in the issue of Tuesday, August 7, 2012, make the following corrections: VerDate Mar<15>2010 16:25 Aug 17, 2012 Jkt 226001 PO 00000 Frm 00085 Importer of Controlled Substances; Notice of Application; Cerilliant Corporation Correction [FR Doc. C1–2012–19199 Filed 8–17–12; 8:45 am] In notice document 2012–19196 appearing on page 47108 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47108, in the first column, the document heading should appear as set forth above. 2. On page 47108, in the second column, in the second full paragraph, in the eighth line of text, ‘‘September 6, 2012’’ should read ‘‘September 19, 2012’’. Drug Enforcement Administration Correction In notice document 2012–19191 appearing on pages 47106–47108 in the issue of Tuesday, August 7, 2012, make the following corrections: 1. On page 47106, in the third column, the document heading should appear as set forth above. 2. On page 4707, in the sixth paragraph following the table, in the eighth line of text, ‘‘September 6, 2012’’ should read ‘‘September 19, 2012’’. Drug Enforcement Administration Fmt 4703 Sfmt 4703 BILLING CODE 1505–01–D DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Almac Clinical Services, Inc. By Notice dated April 17, 2012, and published in the Federal Register on April 26, 2012, 77 FR 24985, Almac Clinical Services, Inc., (ACSI), 25 Fretz Road, Souderton, Pennsylvania 18964, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances: Drug Oxycodone (9143) ........................ Hydromorphone (9150) ................ Tapentadol (9780) ........................ Fentanyl (9801) ............................ Schedule II II II II The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Almac Clinical Services, Inc. (ACSI) to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Almac Clinical Services, Inc. (ACSI) to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s E:\FR\FM\20AUN1.SGM 20AUN1 Federal Register / Vol. 77, No. 161 / Monday, August 20, 2012 / Notices physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Dated: August 7, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2012–20370 Filed 8–17–12; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration; Research Triangle Institute Correction In notice document 2012–19208 appearing on pages 47111–47114 in the issue of Tuesday, August 7, 2012, make the following correction: On page 47111, in the second column, the document heading should appear as set forth above. [FR Doc. C1–2012–19208 Filed 8–17–12; 8:45 am] BILLING CODE 1505–01–D DEPARTMENT OF JUSTICE Drug Enforcement Administration Drug Schedule 4-Anilino-N-phenethyl-4-piperidine (8333). Thebaine (9333) ........................... II II The company plans on manufacturing the listed controlled substances as bulk intermediates for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cody Laboratories, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cody Laboratories, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: August 7, 2012. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. Importer of Controlled Substances; Notice of Registration; Catalent Pharma Solutions, Inc. Correction In notice document 2012–19202 appearing on page 47114 in the issue of Tuesday, August 7, 2012, make the following correction: On page 47114, in the first column, the document heading should appear as set forth above. [FR Doc. C1–2012–19202 Filed 8–17–12; 8:45 am] BILLING CODE 1505–01–D Laboratories, Inc., 601 Yellowstone Avenue, Cody, Wyoming 82414, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances: [FR Doc. 2012–20369 Filed 8–17–12; 8:45 am] BILLING CODE 4410–09–P mstockstill on DSK4VPTVN1PROD with NOTICES Drug Enforcement Administration Manufacturer of Controlled Substances, Notice of Registration, Cody Laboratories, Inc. Mine Safety and Health Administration Affirmative Decisions on Petitions for Modification Granted in Whole or in Part Mine Safety and Health Administration (MSHA), Labor. ACTION: Notice. By Notice dated March 8, 2012, and published in the Federal Register on March 20, 2012, 77 FR 16263, Cody VerDate Mar<15>2010 16:25 Aug 17, 2012 Jkt 226001 Section 101(c) of the Federal Mine Safety and Health Act of 1977 and 30 CFR part 44 govern the application, processing, and disposition of petitions for modification. This Federal Register Notice notifies the public that MSHA has investigated and issued a final SUMMARY: PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 decision on certain mine operator petitions to modify a safety standard. ADDRESSES: Copies of the final decisions are posted on MSHA’s Web Site at https://www.msha.gov/indexes/ petition.htm. The public may inspect the petitions and final decisions during normal business hours in MSHA’s Office of Standards, Regulations and Variances, 1100 Wilson Boulevard, Room 2349, Arlington, Virginia 22209. All visitors must first stop at the receptionist desk on the 21st Floor to sign-in. FOR FURTHER INFORMATION CONTACT: Roslyn B. Fontaine, Office of Standards, Regulations and Variances at 202–693– 9475 (Voice), fontaine.roslyn@dol.gov (Email), or 202–693–9441 (Telefax), or Barbara Barron at 202–693–9447 (Voice), barron.barbara@dol.gov (Email), or 202–693–9441 (Telefax). [These are not toll-free numbers]. SUPPLEMENTARY INFORMATION: I. Introduction Under section 101 of the Federal Mine Safety and Health Act of 1977, a mine operator may petition and the Secretary of Labor (Secretary) may modify the application of a mandatory safety standard to that mine if the Secretary determines that: (1) an alternative method exists that will guarantee no less protection for the miners affected than that provided by the standard; or (2) that the application of the standard will result in a diminution of safety to the affected miners. MSHA bases the final decision on the petitioner’s statements, any comments and information submitted by interested persons, and a field investigation of the conditions at the mine. In some instances, MSHA may approve a petition for modification on the condition that the mine operator complies with other requirements noted in the decision. II. Granted Petitions for Modification DEPARTMENT OF LABOR AGENCY: DEPARTMENT OF JUSTICE 50163 On the basis of the findings of MSHA’s investigation, and as designee of the Secretary, MSHA has granted or partially granted the following petitions for modification: • Docket Number: M–2009–050–C. FR Notice: 75 FR 3256 (1/20/2010). Petitioner: Wolf Run Mining Company, 300 Corporate Centre Drive, Scott Depot, West Virginia 25560. Mine: Sentinel Mine, MSHA I.D. No. 46–04168, located in Barbour County, West Virginia. Regulation Affected: 30 CFR 75.1700 (Oil and gas wells). • Docket Number: M–2009–052–C. FR Notice: 75 FR 3257 (1/20/2010). E:\FR\FM\20AUN1.SGM 20AUN1

Agencies

[Federal Register Volume 77, Number 161 (Monday, August 20, 2012)]
[Notices]
[Pages 50162-50163]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20370]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; Almac 
Clinical Services, Inc.

    By Notice dated April 17, 2012, and published in the Federal 
Register on April 26, 2012, 77 FR 24985, Almac Clinical Services, Inc., 
(ACSI), 25 Fretz Road, Souderton, Pennsylvania 18964, made application 
by renewal to the Drug Enforcement Administration (DEA) to be 
registered as an importer of the following basic classes of controlled 
substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Oxycodone (9143)...........................  II
Hydromorphone (9150).......................  II
Tapentadol (9780)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to import small quantities of the listed 
controlled substances in dosage form to conduct clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a), and determined that the 
registration of Almac Clinical Services, Inc. (ACSI) to import the 
basic classes of controlled substances is consistent with the public 
interest, and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971. DEA has 
investigated Almac Clinical Services, Inc. (ACSI) to ensure that the 
company's registration is consistent with the public interest.
    The investigation has included inspection and testing of the 
company's

[[Page 50163]]

physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic classes of controlled 
substances listed.

    Dated: August 7, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-20370 Filed 8-17-12; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.